182 related articles for article (PubMed ID: 11888024)
1. A population-based study of daily nonsteroidal anti-inflammatory drug use and prostate cancer.
Roberts RO; Jacobson DJ; Girman CJ; Rhodes T; Lieber MM; Jacobsen SJ
Mayo Clin Proc; 2002 Mar; 77(3):219-25. PubMed ID: 11888024
[TBL] [Abstract][Full Text] [Related]
2. Nonsteroidal anti-inflammatory drugs and risk of prostate cancer in the Baltimore Longitudinal Study of Aging.
Platz EA; Rohrmann S; Pearson JD; Corrada MM; Watson DJ; De Marzo AM; Landis PK; Metter EJ; Carter HB
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):390-6. PubMed ID: 15734963
[TBL] [Abstract][Full Text] [Related]
3. A large cohort study of aspirin and other nonsteroidal anti-inflammatory drugs and prostate cancer incidence.
Jacobs EJ; Rodriguez C; Mondul AM; Connell CJ; Henley SJ; Calle EE; Thun MJ
J Natl Cancer Inst; 2005 Jul; 97(13):975-80. PubMed ID: 15998950
[TBL] [Abstract][Full Text] [Related]
4. The impact of the use of aspirin and other nonsteroidal anti-inflammatory drugs on the risk of prostate cancer detection on biopsy.
Bhindi B; Margel D; Hamilton RJ; Fernandes KA; Trottier G; Hersey KM; Finelli A; Trachtenberg J; Zlotta A; Kulkarni GS; Toi A; Evans A; van der Kwast TH; Fleshner NE
Urology; 2014 Nov; 84(5):1073-80. PubMed ID: 25443907
[TBL] [Abstract][Full Text] [Related]
5. Protective association between nonsteroidal antiinflammatory drug use and measures of benign prostatic hyperplasia.
St Sauver JL; Jacobson DJ; McGree ME; Lieber MM; Jacobsen SJ
Am J Epidemiol; 2006 Oct; 164(8):760-8. PubMed ID: 16905643
[TBL] [Abstract][Full Text] [Related]
6. Non-steroidal anti-inflammatory drug use and prostate cancer in a high-risk population.
Mahmud SM; Tanguay S; Bégin LR; Franco EL; Aprikian AG
Eur J Cancer Prev; 2006 Apr; 15(2):158-64. PubMed ID: 16523013
[TBL] [Abstract][Full Text] [Related]
7. Association between nonsteroidal anti-inflammatory drugs and prostate cancer occurrence.
Dasgupta K; Di Cesar D; Ghosn J; Rajan R; Mahmud S; Rahme E
Cancer J; 2006; 12(2):130-5. PubMed ID: 16630404
[TBL] [Abstract][Full Text] [Related]
8. Effects of non-selective non-steroidal anti-inflammatory drugs on the aggressiveness of prostate cancer.
Stock DC; Groome PA; Siemens DR; Rohland SL; Song Z
Prostate; 2008 Nov; 68(15):1655-65. PubMed ID: 18698582
[TBL] [Abstract][Full Text] [Related]
9. Prostate-specific antigen levels in relation to consumption of nonsteroidal anti-inflammatory drugs and acetaminophen: results from the 2001-2002 National Health and Nutrition Examination Survey.
Singer EA; Palapattu GS; van Wijngaarden E
Cancer; 2008 Oct; 113(8):2053-7. PubMed ID: 18780337
[TBL] [Abstract][Full Text] [Related]
10. Aspirin use in relation to risk of prostate cancer.
Leitzmann MF; Stampfer MJ; Ma J; Chan JM; Colditz GA; Willett WC; Giovannucci E
Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):1108-11. PubMed ID: 12376516
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of Prostate-specific Antigen-based Prostate Cancer Screening Among Men Using Nonsteroidal Anti-inflammatory Drugs.
Murtola TJ; Vettenranta AM; Talala K; Taari K; Stenman UH; Tammela TLJ; Auvinen A
Eur Urol Focus; 2018 Dec; 4(6):851-857. PubMed ID: 28753870
[TBL] [Abstract][Full Text] [Related]
12. Nonsteroidal antiinflammatory drugs and decreased risk of advanced prostate cancer: modification by lymphotoxin alpha.
Liu X; Plummer SJ; Nock NL; Casey G; Witte JS
Am J Epidemiol; 2006 Nov; 164(10):984-9. PubMed ID: 16931544
[TBL] [Abstract][Full Text] [Related]
13. NSAIDs and a lower risk of prostate cancer: causation or confounding?
Barry MJ
Mayo Clin Proc; 2002 Mar; 77(3):217-8. PubMed ID: 11888023
[No Abstract] [Full Text] [Related]
14. Nonsteroidal anti-inflammatory drugs and the risk of skin cancer: a population-based case-control study.
Johannesdottir SA; Chang ET; Mehnert F; Schmidt M; Olesen AB; Sørensen HT
Cancer; 2012 Oct; 118(19):4768-76. PubMed ID: 22644960
[TBL] [Abstract][Full Text] [Related]
15. Aspirin, NSAIDs, and risk of prostate cancer: results from the REDUCE study.
Vidal AC; Howard LE; Moreira DM; Castro-Santamaria R; Andriole GL; Freedland SJ
Clin Cancer Res; 2015 Feb; 21(4):756-62. PubMed ID: 25520389
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the incidence of latent prostate cancer detected at autopsy before and after the prostate specific antigen era.
Konety BR; Bird VY; Deorah S; Dahmoush L
J Urol; 2005 Nov; 174(5):1785-8; discussion 1788. PubMed ID: 16217287
[TBL] [Abstract][Full Text] [Related]
17. Prescription channeling of COX-2 inhibitors and traditional nonselective nonsteroidal anti-inflammatory drugs: a population-based case-control study.
Moride Y; Ducruet T; Boivin JF; Moore N; Perreault S; Zhao S
Arthritis Res Ther; 2005; 7(2):R333-42. PubMed ID: 15743481
[TBL] [Abstract][Full Text] [Related]
18. Decline in the overall incidence of regional-distant prostate cancer in Olmsted County, MN, 1980-2000.
Mullan RJ; Jacobsen SJ; Bergstralh EJ; Slezak JM; Tindall DJ; Lieber MM; Roberts RO
BJU Int; 2005 May; 95(7):951-5. PubMed ID: 15839911
[TBL] [Abstract][Full Text] [Related]
19. A prospective study of cruciferous vegetables and prostate cancer.
Giovannucci E; Rimm EB; Liu Y; Stampfer MJ; Willett WC
Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1403-9. PubMed ID: 14693729
[TBL] [Abstract][Full Text] [Related]
20. Decline in prostate cancer mortality from 1980 to 1997, and an update on incidence trends in Olmsted County, Minnesota.
Roberts RO; Bergstralh EJ; Katusic SK; Lieber MM; Jacobsen SJ
J Urol; 1999 Feb; 161(2):529-33. PubMed ID: 9915441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
